Trial intelligence / Profile preview

Varenicline for smoking cessation in HIV-infected patients

NCT00918307Phase 3Completed

Sponsor
ANRS
Start
Oct 2009
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of varenicline in tobacco dependence, sponsored by ANRS. Started Oct 2009; status: completed.

02

Drugs

varenicline
03

Conditions

tobacco dependence

Beyond the preview

Go deeper on NCT00918307.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00918307.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call